These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9355344)

  • 21. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 22. An overview of the fifth-generation implantable cardioverter defibrillator.
    Tanaka S
    Ann Thorac Cardiovasc Surg; 1998 Dec; 4(6):303-11. PubMed ID: 9914457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical predictors and prognostic significance of electrical storm in patients with implantable cardioverter defibrillators.
    Brigadeau F; Kouakam C; Klug D; Marquié C; Duhamel A; Mizon-Gérard F; Lacroix D; Kacet S
    Eur Heart J; 2006 Mar; 27(6):700-7. PubMed ID: 16421175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients with hemodynamically tolerated ventricular tachycardia require implantable cardioverter defibrillators.
    Callans DJ
    Circulation; 2007 Sep; 116(10):1196-203. PubMed ID: 17768303
    [No Abstract]   [Full Text] [Related]  

  • 27. The implantable cardioverter-defibrillator. Current indications and controversies.
    Raj SR; Sheldon RS
    Minerva Cardioangiol; 2002 Aug; 50(4):273-90. PubMed ID: 12147959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple shocks after upgrade of an implantable cardioverter-defibrillator to a cardiac resynchronization therapy-defibrillator device.
    Francisco GM; Sharma S; Dougherty AH; Kantharia BK
    Cardiol J; 2009; 16(5):473-6. PubMed ID: 19753529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
    Rahimtoola SH
    Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of implantable cardioverter defibrillators in the secondary prevention of malignant ventricular arrhythmias: lessons from large studies].
    Anadolu Kardiyol Derg; 2001 Mar; 1(1):43-7, AXIV. PubMed ID: 12132492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
    Moore DR; Kok LC; Vijayaraman P
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
    [No Abstract]   [Full Text] [Related]  

  • 32. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs.
    Singh S; Murawski MM
    J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Avoid delivering therapies for nonsustained fast ventricular tachyarrhythmia in patients with implantable cardioverter/defibrillator: the ADVANCE III Trial.
    Schwab JO; Gasparini M; Lunati M; Proclemer A; Kaup B; Santi E; Ligorio G; Klersy C; DE Sousa J; Okreglicki A; Arenal A; Wijffels M; Lemke B
    J Cardiovasc Electrophysiol; 2009 Jun; 20(6):663-6. PubMed ID: 19175450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists.
    Stevenson WG; Chaitman BR; Ellenbogen KA; Epstein AE; Gross WL; Hayes DL; Strickberger SA; Sweeney MO; ;
    Circulation; 2004 Dec; 110(25):3866-9. PubMed ID: 15611390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming the defects of a virtue: dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study.
    Sweeney MO
    Circulation; 2006 Jun; 113(25):2862-4. PubMed ID: 16801472
    [No Abstract]   [Full Text] [Related]  

  • 37. What is this wide-complex tachycardia and what needs to be done about it?
    Thompson C; Tsiperfal A
    Prog Cardiovasc Nurs; 2001; 16(4):176-7. PubMed ID: 11684911
    [No Abstract]   [Full Text] [Related]  

  • 38. The 1+1 trial: a prospective trial of a dual- versus a single-chamber implantable defibrillator in patients with slow ventricular tachycardias.
    Bänsch D; Steffgen F; Grönefeld G; Wolpert C; Böcker D; Mletzko RU; Schöls W; Seidl K; Piel M; Ouyang F; Hohnloser SH; Kuck KH
    Circulation; 2004 Aug; 110(9):1022-9. PubMed ID: 15326069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and design of the Home Automatic External Defibrillator Trial (HAT).
    Bardy GH; Lee KL; Mark DB; Poole JE; Toff WD; Tonkin AM; Smith W; Dorian P; Yallop JJ; Packer DL; White RD; Longstreth W; Anderson J; Johnson G; Bischoff E; Munkers CD; Brown A; McNulty S; Ray LD; Clapp-Channing NE; Rosenberg Y; Salive M; Schron EB;
    Am Heart J; 2008 Mar; 155(3):445-54. PubMed ID: 18294476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychological and quality-of-life issues in the young patient with an implantable cardioverter-defibrillator.
    DeMaso DR; Neto LB; Hirshberg J
    Heart Rhythm; 2009 Jan; 6(1):130-2. PubMed ID: 18774753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.